Brain Cancer
178
33
42
90
Key Insights
Highlights
Success Rate
78% trial completion
Published Results
34 trials with published results (19%)
Research Maturity
90 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.0%
25 terminated out of 178 trials
78.3%
-8.2% vs benchmark
6%
10 trials in Phase 3/4
38%
34 of 90 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 90 completed trials
Clinical Trials (178)
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations
Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors
Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
A Study to Measure the Effect of Brain Stimulation on Hand Strength and Function in Patients With Brain Tumors
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Precision Radiotherapy Enabled by Molecular MRI
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme